.Merck beats incomes requirements, increases purchases expectation on solid requirement for leading medications like Keytruda CNBCMerck & Co. (MRK United States) Trumps Earnings Projections as Keytruda Purchases Growth BloombergMerck Supply: Pharma Giant Posts Sturdy Results, Yet Expectation Drops Short Real estate investor's Business DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck defeats profit as well as sales requirements in the middle of Keytruda asset, but provides mixed full-year overview MarketWatch.